Evidence map›Paper›PMID 39959399›Full record

ReviewIJTLD open2025

The Western Pacific Regional Framework to End TB: overview and critical reflection.

K H Oh, F Morishita, K Rahevar, R-P Yadav, H T G Tran, G B Marks, M C Raviglione, B J Marais

Abstract readReview
In one paragraph

Review in IJTLD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Strengthening the global Response to Tuberculosis: Insights from the 2024 WHO global TB report.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

K H OhWorld Health Organization Regional Office for the Western Pacific, Manila, Philippines.
F MorishitaWorld Health Organization Regional Office for the Western Pacific, Manila, Philippines.
K RahevarWorld Health Organization Regional Office for the Western Pacific, Manila, Philippines.
R-P YadavWorld Health Organization Regional Office for the Western Pacific, Manila, Philippines.
H T G TranWorld Health Organization Regional Office for the Western Pacific, Manila, Philippines.
G B MarksBurnet Institute, Melbourne, VIC, Australia.
M C RaviglioneCentre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.
B J MaraisSydney Infectious Diseases Institute (Sydney ID) and the WHO Collaborating Centre in Tuberculosis, University of Sydney, Sydney, NSW, Australia.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Despite notable progress, TB remains a critical public health challenge in the Western Pacific Region. To address this, the WHO developed the Western Pacific Regional Framework to End TB, which aligns with global health targets, such as the End TB Strategy and the Sustainable Development Goals. Here, we critically review the Framework, highlighting its strengths and ongoing challenges, with suggestions as to how it might adapt. Although the Framework offers a comprehensive strategy for reducing the TB burden, its success depends on effective implementation across diverse socio-economic contexts. Key obstacles include undiagnosed infectious TB cases, limited healthcare infrastructure, persistent inequities in access to TB services, and drug-resistant TB. The COVID-19 pandemic exacerbated these challenges, disrupting TB services and delaying progress towards 2030 targets. The Framework's reliance on multisectoral partnerships and innovative technologies presents opportunities but requires substantial political commitment, sustained funding and system-wide health reforms. Additionally, gaps remain in addressing social determinants of TB. Ensuring equity, maintaining political will, and fostering international collaboration are essential to overcoming these barriers. Continuous evaluation and adaptation will be crucial in ensuring the Framework's effectiveness in eliminating TB in the Region by 2030.

Indexed as

health equityhealth services accessibilitypublic healthsocio-economic factorstuberculosis

Identifiers

PMID39959399
PMCPMC11827672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.